Skip to content

Development and Validation of a Nomogram for Bladder Outlet Obstruction in Patients with Benign Prostatic Hyperplasia Complicated Bladder Stones

Development and Validation of a Nomogram for Bladder Outlet Obstruction in Patients with Benign Prostatic Hyperplasia Complicated Bladder Stones

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035191
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Gold Standard:urodynamic testing
Index test:The&#32
prediction&#32
model&#32
of&#32
prostatic&#32
hyperplasia&#32
with&#32
outlet&#32
obstruction.

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Age: 40~90 years old; 2. clinical diagnosis of benign prostatic hyperplasia was admitted to the hospital according to the European EAU guidelines and the 2014 Chinese Urological Disease Diagnosis and Treatment Guidelines; 3. PSA < 4ng/ml (patients with excess have been punctured to exclude prostate cancer); 4. Combined with bladder stones; 5. Carry out urodynamic examination; 6. Sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Combined with lower urinary tract symptoms caused by other reasons, such as neurogenic bladder, urethral stricture; 2. Previous history of prostate surgery, urethral surgery, bladder tumor; 3. Pathology after prostatectomy suggests prostate cancer.

Design outcomes

Primary

MeasureTime frame
BOOI;SEN, SPE, ACC, AUC of ROC, PPV, NPV;

Countries

China

Contacts

Public ContactBangmin Han

Shanghai General Hospital

hanbm@163.com+86 18939757031

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026